OurCrowd will invest $2.5 million (as part of a recently completed $7 million investment round) in Scopio Labs, a developer of an advanced digital microscopy and diagnostics platform, a press release states.
OurCrowd Founder and CEO Jon Medved said,
We are excited by our latest investment in Scopio Labs, which is bringing about a revolution in digital microscopy. Scopio Labs joins our portfolio of 23 cutting edge disruptive healthcare technology companies, all of which impact positively the lives of millions of people and are transforming patient care.
Last November the platform launched Israel’s first exclusive digital health fund, OurCrowd Qure, in collaboration with Johns Hopkins University, dedicated to one of the fastest growing sectors in terms of funding and M&A activity.
The OurCrowd community of almost 20,000 investors from over 112 countries has invested over $440M into 120 portfolio companies and funds. OurCrowd already has thirteen exits to date, two IPO’s and eleven acquisitions.
Find out more here.